ValiRx PLC (VAL)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.45p
Buy
0.55p
0.00p (+0.00%)
ValiRx PLC is a biopharmaceutical company. It is engaged in developing technologies and products in oncology therapeutics and diagnostics focused on the treatment of cancer and associated Biomarkers, specializing in epigenomic and genetic analysis.
Prices updated at 01 May 2025, 15:59 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
0.55p - 0.45p | |
4.49p - 0.38p | |
- | |
1.87m | |
- | |
500,000 | |
754,129 | |
0.49 | |
3,673,506.10 | |
-1.00 | |
102.32m | |
GB00BLH13C52 | |
-0.02 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.